Your browser doesn't support javascript.
loading
Surgical management of pancreatic cancer liver oligometastases.
Macfie, Rebekah; Berger, Yael; Sarpel, Umut; Hiotis, Spiros; Golas, Benjamin; Labow, Daniel; Cohen, Noah.
Afiliação
  • Macfie R; The Mount Sinai Hospital, United States.
  • Berger Y; The Mount Sinai Hospital, United States.
  • Sarpel U; The Mount Sinai Hospital, United States.
  • Hiotis S; The Mount Sinai Hospital, United States.
  • Golas B; The Mount Sinai Hospital, United States.
  • Labow D; The Mount Sinai Hospital, United States.
  • Cohen N; The Mount Sinai Hospital, United States. Electronic address: noah.cohen@moutnsinai.org.
Crit Rev Oncol Hematol ; 173: 103654, 2022 May.
Article em En | MEDLINE | ID: mdl-35301097
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article